Stratos Wealth Partners LTD. cut its holdings in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 16.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,761 shares of the company’s stock after selling 1,863 shares during the period. Stratos Wealth Partners LTD.’s holdings in Astera Labs were worth $1,293,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Calamos Advisors LLC bought a new position in Astera Labs in the 4th quarter worth $1,693,000. Renaissance Capital LLC increased its position in Astera Labs by 381.0% in the fourth quarter. Renaissance Capital LLC now owns 114,276 shares of the company’s stock worth $15,136,000 after buying an additional 90,516 shares in the last quarter. Jennison Associates LLC bought a new position in shares of Astera Labs in the fourth quarter worth about $229,991,000. Western Pacific Wealth Management LP purchased a new position in shares of Astera Labs during the 4th quarter valued at about $212,000. Finally, China Universal Asset Management Co. Ltd. bought a new position in shares of Astera Labs during the 4th quarter valued at approximately $3,444,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.
Astera Labs Stock Performance
Shares of ALAB opened at $101.29 on Monday. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $147.39. The business has a fifty day moving average of $122.39 and a 200 day moving average of $81.91.
Analyst Ratings Changes
Read Our Latest Stock Report on Astera Labs
Insider Buying and Selling
In other Astera Labs news, CFO Michael Truett Tate sold 16,000 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $117.84, for a total value of $1,885,440.00. Following the transaction, the chief financial officer now owns 1,412,888 shares of the company’s stock, valued at $166,494,721.92. This represents a 1.12 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Manuel Alba sold 11,000 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total value of $1,292,500.00. Following the completion of the sale, the director now owns 456,863 shares in the company, valued at approximately $53,681,402.50. The trade was a 2.35 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 846,452 shares of company stock valued at $86,427,256.
Astera Labs Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles
- Five stocks we like better than Astera Labs
- Short Selling – The Pros and Cons
- 3 Volatility ETFs to Help You Profit from Market Chaos
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- The How And Why of Investing in Oil Stocks
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.